Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus
Impact of Tele-Interventions During the COVID-19 Pandemic on Glycemic Control and Attitude Toward the Disease in Patients With Diabetes Mellitus - A Randomized Clinical Trial
INTRODUCTION In critical situations, such as the current COVID 19 pandemic, themes of fear, uncertainty and stigmatization are common and constitute barriers to appropriate medical and mental health interventions. These challenges, when faced by those who live with a chronic disease, such as diabetes mellitus (DM), can negatively influence quality of life and adherence to treatment, compromising the control of the disease.
OBJECTIVES The present study aims to investigate the effectiveness of a tele-intervention during the COVID-19 pandemic in improving glycemic control, lipid profile, blood pressure levels and parameters of medication adherence, mental well-being and sleep quality in patients with type 1 DM and type 2 DM.
METHODS A randomized clinical trial will be carried out with patients with a previous diagnosis of type 1 DM and type 2 DM, who are registered at the Hospital de Clínicas de Porto Alegre (HCPA). Inclusion criteria will be age greater than or equal to 18 years, collection of HbA1c in the HCPA laboratory in January, February or March 2020 and availability to receive weekly phone calls. Patients will be randomized, stratified by type of diabetes, in two groups: G1: participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the social distancing period ; G2: participants will receive the usual care. The primary outcome assessed will be the variation in HbA1c levels comparatively between groups, with or without a tele-guided strategy, after four months of social distancing (or as long as the recommendation of social distancing measures remains). Secondary outcomes will include experiencing confirmation of COVID-19 infection, variation in lipid profile, blood pressure levels and variation in parameters of emotional distress related to diabetes, eating disorders, medication adherence, symptoms minor psychiatric disorders and altered sleep patterns, which will be evaluated with specific and validated scales. According to the sample calculation, 150 patients will be included in the study (92 with type 2 DM and 58 with type 1 DM). Analysis by intention to treat will be performed separately for patients with type 1 DM and with type 2 DM.
SCHEDULE The proposed experiment will start immediately after approval of this project by the research ethics committee. The duration of the proposed intervention is 4 months (or as long as the recommendation of social distancing measures remains. This means that the study may be completed before or after that period, based on national recommendations for social distancing in Brazil), with a data analysis plan and publication of the results until September 2020.
研究概览
地位
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Rio Grande Do Sul
-
Porto Alegre、Rio Grande Do Sul、巴西、90620-170
- Hospital de Clinicas de Porto Alegre
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Type 1 diabetes mellitus or type 2 diabetes mellitus;
- Age greater than or equal to 18 years;
- HbA1c assessed in January, February or March 2020;
- Availability to receive weekly phone calls
Exclusion Criteria:
- Any severe cognitive limitation that prevents the necessary interaction to carry out this study (advanced dementia, deafness, dysarthria, aphasia);
- Do not present a telephone record in an electronic medical record;
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Tele-Intervention
Participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period
|
Participants will receive a tele-intervention by a case manager weekly to discuss topics related to diabetes management and mental well-being during the quarantine period
|
|
无干预:Usual Care
Participants will receive the usual care
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Variation in HbA1c levels
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Variation in HbA1c levels comparatively between groups after the period of social distancing measures.
|
4 months (or as long as the recommendation of social distancing measures remains)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
COVID-19 infection
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Confirmation of coronavirus infection by rapid test
|
4 months (or as long as the recommendation of social distancing measures remains)
|
|
Variation in lipid profile
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Comparison of the lipid profile of the last year with the lipid profile after the intervention between the groups.
|
4 months (or as long as the recommendation of social distancing measures remains)
|
|
Variation in blood pressure levels
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Comparison of the blood pressure level of the last consultation with the pressure after the intervention between the groups.
|
4 months (or as long as the recommendation of social distancing measures remains)
|
|
Comparison of emotional distress associated with the routine of living with diabetes after intervention between groups
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Evaluation of emotional distress associated with the routine of living with diabetes - B-PAID (Brazilian Problem Areas In Diabetes Scale)
|
4 months (or as long as the recommendation of social distancing measures remains)
|
|
Comparison of eating disorders between groups
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Evaluation of eating disorders - EAT - 26 SCALE (Teste de Atitudes Alimentares)
|
4 months (or as long as the recommendation of social distancing measures remains)
|
|
Comparison of adherence to the proposed clinical treatment between groups
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Evaluation of adherence to the proposed clinical treatment - SCI R (Self-Care Inventory - revised)
|
4 months (or as long as the recommendation of social distancing measures remains)
|
|
Comparison of minor psychiatric disorders between groups
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Evaluation of minor psychiatric disorders - SRQ 20 (Self Report Questionnaire)
|
4 months (or as long as the recommendation of social distancing measures remains)
|
|
Comparison of sleep pattern changes between groups
大体时间:4 months (or as long as the recommendation of social distancing measures remains)
|
Evaluation of sleep pattern changes - MSQ (Mini Sleep Questionnaire)
|
4 months (or as long as the recommendation of social distancing measures remains)
|
合作者和调查者
出版物和有用的链接
一般刊物
- Alessi J, Becker AS, Amaral B, de Oliveira GB, Franco DW, Knijnik CP, Kobe GL, de Brito A, de Carvalho TR, Telo GH, Schaan BD, Telo GH. Type 1 diabetes and the challenges of emotional support in crisis situations: results from a feasibility study of a multidisciplinary teleintervention. Sci Rep. 2022 May 20;12(1):8526. doi: 10.1038/s41598-022-12227-z.
- Alessi J, Becker AS, Amaral B, de Oliveira GB, Franco DW, Knijnik CP, Kobe GL, de Brito A, de Carvalho TR, Telo GH, Schaan BD, Telo GH. Type 1 diabetes and the challenges of emotional support in crisis situations: results from a randomized clinical trial of a multidisciplinary teleintervention. Sci Rep. 2022 Feb 23;12(1):3086. doi: 10.1038/s41598-022-07005-w.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他相关的 MeSH 术语
其他研究编号
- 2020241093
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
- 分析代码
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.